Royal Bank Of Canada In Med Pharmaceuticals Inc. Transaction History
Royal Bank Of Canada
- $425 Billion
- Q2 2024
A detailed history of Royal Bank Of Canada transactions in In Med Pharmaceuticals Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 25 shares of INM stock, worth $6. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 25
-0.0%
Holding current value
$6
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding INM
# of Institutions
16Shares Held
463KCall Options Held
0Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ307KShares$73,7365.39% of portfolio
-
Virtu Financial LLC New York, NY86.7KShares$20,8040.0% of portfolio
-
Baader Bank Aktiengesellschaft Unterschleissheim, 2M22.6KShares$5,4260.0% of portfolio
-
Xtx Topco LTD London, X017.8KShares$4,2760.0% of portfolio
-
Hrt Financial LP New York, NY16KShares$3,8390.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $218K
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...